In vitroactivity of clarithromycin in combination with other antimicrobial agents against biofilm-formingPseudomonas aeruginosastrains
Authors:
- B. KádárBKB. Kádár
- M. SzászMSM. Szász
- Katalin KristófKKKatalin Kristóf
- Natasa PestiNPNatasa Pesti
- G. KrizsánGKG. Krizsán
- Julianna SzentandrássyJSJulianna Szentandrássy
- L. RókuszLRL. Rókusz
- K. NagyKNK. Nagy
- Dóra SzabóDSDóra Szabó
- 1 September 2010
- journal article
- research article
- Published by Akademiai Kiado Zrt. in Acta Microbiologica Et Immunologica Hungarica
- Vol. 57 (3) , 235-245
Abstract
The aim of the study was to investigate the biofilm-production of 60 Pseudomonas aeruginosa strains isolated from clinical samples and to examine the effect of different antimicrobials and their combinations with clarithromycin on biofilm-formation. The minimal inhibitory concentrations (MICs), minimal biofilm inhibitory concentrations (MBICs), and antibiotic synergy by calculating the fractional inhibitory concentration (FIC) index were determined for the following antibiotics: ceftazidime, cefepime, piperacillin/tazobactam, imipenem, meropenem, levofloxacin, ciprofloxacin, gentamicin, amikacin, tobramycin, netilmicin and clarithromycin. A total of 14 (23.3%) isolates out of 60 isolates of P. aeruginosa were biofilm positive. Cefepime, imipenem and meropenem had the lowest MIC 90 values. Piperacillin/tazobactam and clarithromycin had the highest MIC 90 values. Imipenem, meropenem, piperacillin/tazobactam and clarithromycin had the lowest MBIC 90 values. For biofilm-forming P. aeruginosa strains 2-fold to 128-fold higher MBIC values than MIC values were obtained for ceftazidime, cefepime, imipenem, amikacin and netilmicin. The MBIC was 2-fold to 512-fold lower then the MIC values in the case of piperacillin/tazobactam, ciprofloxacin, levofloxacin and clarithromycin. Synergy was generally demonstrated for clarithromycin in combination with aminoglycosides, fluoroquinolones or ceftazidime. However, surprisingly it was found that combinations of clarithromycin with carbapenems or cefepime led to an antagonistic interaction: combination of clarithromycin with imipenem, meropenem or ertapenem showed antagonism in 37.5%, 50% and 62.5% of the strains tested whereas its combination with cefepime expressed antagonism in 75% of the strains, respectively. To the best of our knowledge no one has previously described this phenomenon so far.Keywords
This publication has 21 references indexed in Scilit:
- Azithromycin in Pseudomonas aeruginosa Biofilms: Bactericidal Activity and Selection of nfxB MutantsAntimicrobial Agents and Chemotherapy, 2009
- Increased bacterial adherence and biomass in Pseudomonas aeruginosa bacteria exposed to clarithromycinDiagnostic Microbiology and Infectious Disease, 2009
- Macrolide Antibiotic-Mediated Downregulation of MexAB-OprM Efflux Pump Expression in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2008
- Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2008
- In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic culturesInternational Journal of Antimicrobial Agents, 2008
- Clarithromycin has an immunomodulatory effect on ERK-mediated inflammation induced by Pseudomonas aeruginosa flagellinJournal of Antimicrobial Chemotherapy, 2007
- Effect of Erythromycin on Chronic Respiratory Infection Caused byPseudomonas aeruginosawith Biofilm Formation in an Experimental Murine ModelAntimicrobial Agents and Chemotherapy, 2004
- Synergistic Activities of Macrolide Antibiotics against Pseudomonas aeruginosa , Burkholderia cepacia , Stenotrophomonas maltophilia , and Alcaligenes xylosoxidans Isolated from Patients with Cystic FibrosisAntimicrobial Agents and Chemotherapy, 2002
- Effect of Clarithromycin on Pseudomonas aeruginosa BiofilmsChemotherapy, 1999
- Antibiotic Susceptibility of Multiply Resistant Pseudomonas aeruginosa Isolatedfrom Patients with Cystic Fibrosis, Including Candidates for TransplantationClinical Infectious Diseases, 1996